Price
$51.18
$51.18 +5.1% today · NYQ
The KC Score is a transparent, rules-based read of price behaviour — momentum, trend, range position and volatility. It describes what the price has done; it says nothing about whether a company is a good business or a good buy. Not financial advice. Capital at risk.
Brokers we rate for UK investors. King Compound is not regulated by the FCA and this is not a recommendation — do your own research. Capital at risk.
The KC Score for GSK is 46/100 (C). Mixed / range-bound — no clear trend in the data right now. This is a descriptive, rules-based read of price behaviour — momentum, trend, 52-week range position and volatility — not investment advice, a recommendation or a price target. Whether GSK suits you depends on your own goals, timeframe and risk tolerance.
GSK scores 46 out of 100, a grade of C. The KC Score blends four transparent factors — momentum, trend, range position and volatility — computed from roughly one year of price data. It measures what the price has done, not the quality of the underlying business.
GSK shows annualised volatility of about 26%. Over the last three months it has moved -3.4% and over six months +1.3%. It currently trades -17.1% from its 52-week high. Past performance does not predict future returns.
Want the calm way to actually invest? One framework a week — plain English, free.
Join The Compound Letter Analyse another →